Gene Therapy 'Vant' Unveiled As Dainippon, Roivant Finalize $3bn Deal
Broad Alliance Involves New Entities
Japanese firm signs definitive agreement to acquire Roivant's interests in five 'vants' initially, including new gene therapy operation, as ex-Genentech president named head of new entity.
